19 May 2013
Keywords: ardea, gets, go-ahead, ph, rdea594, uk, trial
Article | 01 September 2008
The USA's Ardea Biosciences says that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorized a Phase I ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 September 2008
17 May 2013
© 2013 thepharmaletter.com